VNDA ▲ +10.8% - Vanda Pharmaceuticals Inc.
$VNDA VNDA - Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder
29-SEP-2026 06:46 PM ET
Share this post
More filings for $VNDA
VNDA ▲ +1.8% - Vanda Pharmaceuticals Inc.Sep 2, 2026VNDA - Vanda Pharmaceuticals Inc. - SEC Filing Update (19-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 19, 2026VNDA - Vanda Pharmaceuticals Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $VNDA filing history →💬 Comments
Loading comments…
Leave a comment